Clinical Trial

A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

Study acronym: DW-EAZ-OS01
Completed
View on ClinicalTrials.gov →
Summary
A prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older
Trial Details
NCT Number NCT07489183
Lead Sponsor Dong Wha Pharmaceutical Co. Ltd.
Conditions Hypercholesterolemia
Enrollment 641 participants
Start Date 2021-08-23
Primary Completion 2023-09-07 (estimated)
Study Completion 2023-09-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-24